Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

ChemoTech's Animal Care Celebrates Record-Breaking Month with Order Intake of 200,000 USD in April

Scandinavian ChemoTech
Download the release

Scandinavian ChemoTech is proud to announce a record-breaking performance in April, with order intake near the total for the entire first quarter of the year. This achievement marks a significant milestone and sets a strong tone for the beginning of Q2.

"We are thrilled with the momentum we have seen as we move into the second quarter," said Mohan Frick, CEO. "Nearing our Q1 order volume in just one month is a testament to the hard work of our team and the trust our customers place in Tumor-Specific Electroporation (TSE)."

 

While the company is optimistic about the trajectory for Q2, the sales forecast for the remainder of the quarter is still uncertain. "While we are encouraged by this strong start, it's too early to project how the rest of the quarter will unfold," said Ann Ohlsson, Head of finance.

This disclosure contains information that ChemoTech is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on "Innehållet inom klamrarna kommer ersättas med rätt tid och datum vid utskickstillfället">01-05-2025 06:15 CET.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.